Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hualuo is a Beijing-based medical technology company specializing in advanced neural regulation and electronic pulse therapy. The company has developed a proprietary neural therapy system designed to treat chronic pain and assist in neurological rehabilitation by stimulating nerve fibers through non-invasive electronic pulses. Their core product line includes clinical and portable devices targeted at indications such as stroke recovery, diabetic neuropathy, and musculoskeletal pain. Hualuo integrates traditional medical theory with modern electronic engineering to provide alternative treatments for patients with difficult-to-manage neurological conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hua Luo.